Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Matteo Zimatore
Observed names:
M. Zimatore,
Matteo ZIMATORE
Institution:
Fondazione IRCCS Istituto Nazionale dei Tumori
Observed institutions:
Policlinico San Matteo Fondazione,
Fondazione IRCCS Istituto Nazionale dei Tumori,
European Institute of Oncology
ORCID:
0009-0009-5002-6640
Observed ORCID:
0009-0009-5002-6640
OpenAlex ID:
A5016147989
Raltitrexed–Oxaliplatin combination chemotherapy is inactive as second-line treatment for malignant pleural mesothelioma patients
2005
·
Camillo Porta
, Matteo Zimatore
, et al.
·
Lung Cancer
·
53
Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer
1999
·
O. Pagani
, C. Sessa
, et al.
·
Annals of Oncology
·
46
PDF
Cancer-related fatigue and depression: a monocentric, prospective, cross-sectional study in advanced solid tumors
2022
·
R. Lobefaro
, S. Rota
, et al.
·
ESMO Open
·
42
PDF
Gemcitabine and oxaliplatin in the treatment of patients with immunotherapy‐resistant advanced renal cell carcinoma: Final results of a single‐institution Phase II study
2004
·
Camillo Porta
, Matteo Zimatore
, et al.
·
Cancer
·
26
PDF
Weekly taxanes in metastatic breast cancer (Review)
2002
·
Matteo Zimatore
, Marco Danova
, et al.
·
Oncology Reports
·
17
Dose-finding study of paclitaxel and cyclophosphamide in advanced breast cancer
1997
·
O. Pagani
, C. Sessa
, et al.
·
Annals of Oncology
·
15
PDF
Intrapleural interleukin-2 induces nitric oxide production in pleural effusions from malignant mesothelioma: A possible mechanism of interleukin-2-mediated cytotoxicity?
2002
·
Camillo Porta
, Vittoria Rizzo
, et al.
·
Lung Cancer
·
11
mRNA-Based Urine Test Performance in High and Very-High Risk Non–Muscle-Invasive Bladder Cancer Patients Undergoing Contextual Endoscopic Follow-up (VERNAL: Vesical Tumor Early Monitoring: mRNA-Based Follow-up)
2025
·
Alberto Macchi
, Martina Bruniera
, et al.
·
Clinical Genitourinary Cancer
·
7
Pro-neoangiogenic cytokines (VEGF and bFGF) and anemia in solid tumor patients
2005
·
Camillo Porta
, Ilaria Imarisio
, et al.
·
Oncology Reports
·
7
Laparoscopic retroperitoneal lymph-node dissection in metastatic nonseminomatous germ-cell tumors
2022
·
Sebastiano Nazzani
, Silvia Stagni
, et al.
·
European Journal of Surgical Oncology
·
6
Surveillance or Dynamic Sentinel Lymph-Node Biopsy in Low-Risk Clinically N0 Penile Squamous Cell Carcinoma: Single-Institution Real World Data
2024
·
Sebastiano Nazzani
, Mario Catanzaro
, et al.
·
Clinical Genitourinary Cancer
·
2
Targeting Cyclin-Dependent Kinase 4 Amplifications: A Pioneering Case of Metastatic Leydig Cell Tumor Responding to Abemaciclib
2025
·
Amedeo Nuzzo
, Marco Barella
, et al.
·
JCO Precision Oncology
·
1
177 Lu-PSMA-617 radioligand therapy as an immune modulator in prostate cancer
2026
·
Carolina Sciortino
, Amedeo Nuzzo
, et al.
·
Expert Review of Anticancer Therapy
Management of monorchid patients with previous testis cancer: the role of frozen sections and the real possibility of testis sparing surgery in a large retrospective series
2026
·
Sebastiano NAZZANI
, Ruggero DARISI
, et al.
·
Minerva Urology and Nephrology
Clinical outcomes of Stage I (SI) elderly patients (pts) affected by Germ-Cell Tumors (GCTs): A retrospective multicentric study (IGG07 trial)
2025
·
A. Nuzzo
, A. Marmiroli
, et al.
·
European Urology Open Science
1051P Clinical outcomes of clinical stage I (CSI) elderly patients (pts) affected by germ-cell tumors (GCTs): A retrospective multicentric study (IGG07 trial)
2025
·
A. Nuzzo
, A. Marmiroli
, et al.
·
Annals of Oncology
PDF
1048P Real-worl outcomes of metastatic germ-cell tumors (GCTs) in patients aged over 45. (study-IGG07)
2025
·
F. Mascaro
, A. marmiroli
, et al.
·
Annals of Oncology
Organ preservation and oncological efficacy of peniscopically controlled CO2 laser excision of penile squamous cell carcinoma: Early and late results in a high-volume center
2025
·
Sebastiano Nazzani
, Vito Lorusso
, et al.
·
Urologic Oncology Seminars and Original Investigations
Primary Retroperitoneal Germ-Cell Tumours (pR-GCT): Evaluation of Treatment Outcomes of An International Collaboration (PRIMERE Study-IGG05)
2025
·
Patrizia Giannatempo
, Sebastiano Nazzani
, et al.
·
SSRN Electronic Journal
MP61-16 INTRAOPERATIVE INDOCYANINE GREEN FLUORESCENCE ANGIOGRAPHY IN INGUINAL WITH OR WITHOUT PELVIC LYMPH-NODE DISSECTION FOR PENILE SQUAMOUS CELL CARCINOMA (PeSCC)
2024
·
Carlo Silvani
, Sebastiano Nazzani
, et al.
·
The Journal of Urology
PDF
MP61-17 ORGAN PRESERVATION AND ONCOLOGICAL EFFICACY OF PENISCOPICALLY CONTROLLED CO2 LASER EXCISION OF PENILE SQUAMOUS CELL CARCINOMA: EARLY AND LATE RESULTS IN a HIGH-VOLUME CENTER
2024
·
Carlo Silvani
, Vito Lorusso
, et al.
·
The Journal of Urology
PDF
Organ preservation and oncological efficacy of peniscopically controlled CO2 laser excision of penile squamous cell carcinoma: Early and late results in a high-volume center
2024
·
C. Silvani
, V. Lorusso
, et al.
·
European Urology
Primary retroperitoneal germ-cell tumors (pR-GCT): Evaluation of treatment outcomes of an international collaboration (PRIMERE study-IGG05)
2024
·
S. Nazzani
, P. Giannatempo
, et al.
·
European Urology
12P Do retroperitoneal extragonadal germ cell tumours (pR-GCT) exist? Evaluation of treatment outcomes of an international retrospective collaboration (PRIMERE study-IGG05)
2024
·
C. Cavalli
, E. Gusmaroli
, et al.
·
ESMO Open
Peripheral biomarker analysis in patients with advanced urothelial carcinoma (UC) after platinum chemotherapy treated with cabozantinib (CABO) plus durvalumab (DURVA): Preliminary analysis from the phase 2 ARCADIA trial.
2024
·
Patrizia Giannatempo
, Francesco Sgambelluri
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
32
Citation count:
233
H-index:
7
I10-index:
7
Year
Topic
Type